United States · FDA National Drug Code directory
Qbrexza
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69489-411_52537ea0-9410-1691-e063-6394a90a9468
- Product NDC
- 69489-411
- Form
- CLOTH
- Composition / generic term
- glycopyrronium
- Labeler
- Journey Medical Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180628
- Source listing expiry
- 20271231
Source-listed ingredients
- GLYCOPYRRONIUM TOSYLATE — 2.4 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 5 POUCH in 1 CARTON (69489-411-05) / 2.8 g in 1 POUCH (69489-411-51) · 69489-411-05
- 30 POUCH in 1 CARTON (69489-411-30) / 2.8 g in 1 POUCH (69489-411-01) · 69489-411-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →